Animal Feed · Founded 1991 · www.godrejagrovet.com · BSE 540743 · NSE GODREJAGRO · ISIN INE850D01014
No Notes Added Yet
Business
Godrej Agrovet Ltd. (GAVL) is a diversified agri-business company engaged in various segments of the Indian agricultural sector. Its core business revolves around manufacturing and marketing products that enhance agricultural productivity and animal health. GAVL makes money by selling a wide range of products including animal feed (for poultry, cattle, aqua), crop protection products (insecticides, herbicides, fungicides, plant growth regulators), oil palm products (crude palm oil, palm kernel cake), dairy products (milk, curd, ghee under Jersey brand), processed poultry and vegetarian products (under Godrej Yummiez brand), and innovative farm inputs. It operates on an integrated farm-to-fork model in some segments, serving both B2B customers (e.g., large poultry farms, dairies) and B2C consumers.
Revenue Mix
Godrej Agrovet's major business segments include:
Animal Feed: This is historically its largest segment, manufacturing and selling compound feed for cattle, poultry, and aquaculture.
Crop Protection: Production and sale of pesticides, herbicides, fungicides, and plant growth regulators.
Oil Palm: Cultivation of oil palm and processing fresh fruit bunches into crude palm oil and palm kernel cake.
Dairy: Procurement, processing, and sale of milk and milk products.
Poultry & Processed Foods: Integrated poultry operations, and sale of processed chicken and vegetarian products.
Aqua Feed: Specialized feed for various aquatic species.
While exact, constantly updated revenue percentages are dynamic, Animal Feed typically constitutes the largest portion of its revenue, followed by Crop Protection, and then the other segments.
Industry
GAVL operates in diverse but interconnected agri-business industries in India. The animal feed industry is large and growing, driven by increasing demand for protein, but also fragmented with many regional players. GAVL is a leading player in the organized animal feed sector. The crop protection market is also significant, with global and domestic players, where GAVL holds a strong position, particularly with its distribution network. The Indian oil palm industry is nascent but strategic, with government impetus, where GAVL is a frontrunner in cultivation and processing. Its positioning benefits from the strong brand legacy of the Godrej Group, extensive distribution networks, and an integrated approach in several value chains, differentiating it from purely specialized players.
MOAT
Brand Reputation: Association with the trusted Godrej brand provides a significant advantage in both B2B and B2C markets, fostering customer loyalty and ease of market entry.
Scale & Integration: GAVL's large-scale operations in animal feed and oil palm provide economies of scale in procurement, manufacturing, and distribution. Its integrated model, particularly in poultry and dairy, offers some supply chain resilience and value capture across the chain.
Extensive Distribution Network: A vast network, especially in rural and semi-urban areas, provides a significant reach for its animal feed and crop protection products, which is hard for new entrants to replicate.
R&D and Technical Expertise: Focus on scientific formulations for animal feed and crop protection, coupled with agronomic expertise in oil palm, enables product differentiation and efficiency.
Growth Drivers
Rising Protein Consumption: Increasing per capita income and urbanization in India are driving higher demand for poultry, dairy, and aqua products, directly boosting demand for animal feed.
Shift to Organized Farming: The trend towards commercial and organized dairy, poultry, and aquaculture farming favors large, quality-focused feed producers like GAVL.
Government Initiatives for Oil Palm: The National Mission on Edible Oils – Oil Palm (NMEO-OP) aims to boost domestic oil palm cultivation, providing a significant tailwind for GAVL's oil palm business.
Demand for High-Quality Inputs: Growing awareness among farmers about better crop protection and animal nutrition products for improved yields and animal health.
Portfolio Diversification & Value-Added Products: Expansion into processed foods (Yummiez) and higher-margin dairy products offers new avenues for growth and better margins.
Risks
Commodity Price Volatility: Significant exposure to price fluctuations of key raw materials like maize, soya, and crude palm oil, which can impact profitability.
Disease Outbreaks: Outbreaks of diseases in livestock (e.g., Avian Flu, Lumpy Skin Disease) can severely impact demand for animal feed and poultry products.
Monsoon & Weather Dependence: As an agri-business, performance is susceptible to the vagaries of the monsoon and other adverse weather conditions affecting crop yields and raw material availability.
Regulatory & Policy Changes: Changes in government policies related to agriculture, imports/exports, subsidies, and environmental regulations can impact operations and profitability.
Intense Competition: Competition from numerous domestic and international players across its various segments, particularly in animal feed and crop protection.
Supply Chain Disruptions: Global or domestic events can disrupt the supply chain for raw materials or distribution of finished goods.
Management & Ownership
Godrej Agrovet Ltd. is part of the diversified Godrej Group, one of India's oldest and most respected conglomerates. Godrej Industries Ltd. is the promoter, holding a significant stake (around 58%). The company benefits from the group's professional management philosophy and established corporate governance practices. The management team typically comprises experienced professionals with deep industry knowledge, leveraging the broader Godrej ecosystem for talent and strategic direction.
Outlook
Godrej Agrovet is positioned to benefit from the long-term structural growth trends in Indian agriculture, driven by increasing population, rising disposable incomes, and evolving dietary preferences towards protein. Its strong brand, integrated business model, and extensive reach provide a solid foundation. The company's focus on R&D and diversification into value-added products can drive sustainable growth. However, the business remains inherently exposed to commodity price volatility, agricultural cycles, and disease risks. While government support for agriculture (e.g., oil palm mission) offers tailwinds, intense competition across segments necessitates continuous innovation and efficient operations to maintain market share and profitability.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 2134 | 2351 | 2449 | 2450 | 2134 | 2614 | 2567 | 2718 | 2333 | 2855 |
| Other Income | 10 | 9 | 13 | 9 | 13 | 12 | 8 | 18 | 68 | 15 |
| Total Income | 2144 | 2360 | 2461 | 2458 | 2147 | 2626 | 2575 | 2737 | 2400 | 2870 |
| Total Expenditure | 1986 | 2125 | 2225 | 2230 | 1987 | 2345 | 2354 | 2477 | 2194 | 2615 |
| Operating Profit | 158 | 235 | 236 | 229 | 160 | 282 | 221 | 260 | 207 | 255 |
| Interest | 25 | 30 | 40 | 34 | 29 | 35 | 40 | 35 | 29 | 30 |
| Depreciation | 56 | 55 | 58 | 57 | 56 | 58 | 57 | 56 | 58 | 57 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -30 | 0 | 0 |
| Profit Before Tax | 77 | 151 | 138 | 138 | 74 | 188 | 125 | 139 | 120 | 169 |
| Provision for Tax | 22 | 34 | 54 | 41 | 20 | 52 | 51 | 37 | 28 | 53 |
| Profit After Tax | 55 | 116 | 84 | 96 | 54 | 137 | 74 | 102 | 92 | 116 |
| Adjustments | 2 | 19 | 29 | 15 | 17 | 24 | 19 | 13 | 12 | 19 |
| Profit After Adjustments | 57 | 135 | 112 | 111 | 71 | 161 | 93 | 115 | 105 | 135 |
| Adjusted Earnings Per Share | 3 | 7 | 5.8 | 5.8 | 3.7 | 8.3 | 4.8 | 6 | 5.5 | 7 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 4298 | 4911 | 5186 | 5918 | 6965 | 6268 | 8306 | 9374 | 9561 | 9383 | 10233 | 10473 |
| Other Income | 55 | 59 | 32 | 53 | 47 | 40 | 80 | 111 | 41 | 49 | 106 | 109 |
| Total Income | 4353 | 4970 | 5217 | 5971 | 7011 | 6307 | 8386 | 9485 | 9602 | 9431 | 10339 | 10582 |
| Total Expenditure | 3969 | 4473 | 4743 | 5462 | 6476 | 5704 | 7641 | 8855 | 8859 | 8572 | 9369 | 9640 |
| Operating Profit | 383 | 497 | 475 | 509 | 535 | 603 | 745 | 630 | 743 | 860 | 969 | 943 |
| Interest | 61 | 86 | 45 | 34 | 42 | 46 | 63 | 99 | 108 | 133 | 138 | 134 |
| Depreciation | 62 | 75 | 86 | 98 | 148 | 154 | 173 | 185 | 214 | 226 | 229 | 228 |
| Exceptional Income / Expenses | -6 | 20 | 12 | 88 | -10 | 0 | -17 | 0 | 0 | 0 | -30 | -30 |
| Profit Before Tax | 254 | 375 | 372 | 477 | 349 | 453 | 542 | 378 | 473 | 554 | 612 | 553 |
| Provision for Tax | 69 | 102 | 121 | 128 | 48 | 106 | 122 | 82 | 113 | 150 | 167 | 169 |
| Profit After Tax | 185 | 273 | 251 | 349 | 301 | 348 | 419 | 295 | 359 | 403 | 445 | 384 |
| Adjustments | 5 | -24 | -22 | -20 | 6 | -34 | -17 | 7 | 0 | 26 | 28 | 63 |
| Profit After Adjustments | 189 | 249 | 229 | 329 | 306 | 314 | 403 | 302 | 360 | 430 | 473 | 448 |
| Adjusted Earnings Per Share | 10.2 | 13.4 | 11.9 | 17.1 | 15.9 | 16.3 | 21 | 15.7 | 18.7 | 22.3 | 24.6 | 23.3 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 9% | 3% | 10% | 9% |
| Operating Profit CAGR | 13% | 15% | 10% | 10% |
| PAT CAGR | 10% | 15% | 5% | 9% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -9% | 9% | 0% | NA% |
| ROE Average | 20% | 17% | 17% | 21% |
| ROCE Average | 21% | 18% | 17% | 20% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 769 | 1009 | 1411 | 1649 | 1838 | 2051 | 2268 | 2338 | 2517 | 2381 | 2032 |
| Minority's Interest | 133 | 254 | 269 | 401 | 382 | 410 | 420 | 406 | 404 | 222 | 132 |
| Borrowings | 46 | 21 | 14 | 64 | 43 | 149 | 47 | 55 | 293 | 456 | 817 |
| Other Non-Current Liabilities | 121 | 215 | 187 | 232 | 199 | 197 | 185 | 267 | 260 | 245 | 252 |
| Total Current Liabilities | 1981 | 1709 | 1653 | 1884 | 2210 | 1972 | 2636 | 2378 | 2193 | 2202 | 2929 |
| Total Liabilities | 3051 | 3208 | 3535 | 4230 | 4672 | 4779 | 5557 | 5444 | 5667 | 5505 | 6161 |
| Fixed Assets | 1225 | 1477 | 1496 | 2070 | 2178 | 2298 | 2407 | 2568 | 2806 | 2912 | 2796 |
| Other Non-Current Assets | 250 | 308 | 461 | 289 | 361 | 337 | 353 | 571 | 576 | 400 | 593 |
| Total Current Assets | 1576 | 1422 | 1578 | 1871 | 2132 | 2144 | 2796 | 2305 | 2284 | 2187 | 2759 |
| Total Assets | 3051 | 3208 | 3535 | 4230 | 4672 | 4779 | 5557 | 5444 | 5667 | 5505 | 6161 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 16 | 31 | 54 | 30 | 28 | 49 | 49 | 31 | 27 | 50 | 37 |
| Cash Flow from Operating Activities | 159 | 897 | 354 | 448 | 240 | -10 | -120 | 874 | 678 | 969 | 1281 |
| Cash Flow from Investing Activities | -520 | -63 | -253 | -237 | -255 | -179 | -208 | -284 | -327 | -82 | -150 |
| Cash Flow from Financing Activities | 369 | -812 | -125 | -217 | 36 | 189 | 311 | -594 | -328 | -901 | -869 |
| Net Cash Inflow / Outflow | 9 | 22 | -24 | -6 | 21 | -0 | -17 | -5 | 23 | -13 | 262 |
| Closing Cash & Cash Equivalent | 39 | 54 | 30 | 28 | 49 | 49 | 31 | 27 | 50 | 37 | 299 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 10.23 | 13.44 | 11.94 | 17.13 | 15.94 | 16.33 | 20.96 | 15.71 | 18.71 | 22.35 | 24.58 |
| CEPS(Rs) | 13.34 | 18.77 | 17.55 | 23.3 | 23.36 | 26.11 | 30.84 | 25.02 | 29.85 | 32.74 | 35.05 |
| DPS(Rs) | 2.22 | 0 | 4.5 | 4.5 | 5.5 | 8 | 9.5 | 9.5 | 10 | 11 | 11 |
| Book NAV/Share(Rs) | 35.8 | 54.4 | 73.41 | 85.72 | 95.5 | 106.56 | 117.81 | 121.34 | 130.59 | 123.51 | 105.12 |
| Core EBITDA Margin(%) | 7.64 | 8.89 | 8.51 | 7.39 | 6.82 | 8.74 | 7.77 | 5.36 | 7.03 | 8.25 | 8.04 |
| EBIT Margin(%) | 7.32 | 9.36 | 8.01 | 8.29 | 5.45 | 7.74 | 7.06 | 4.92 | 5.82 | 6.99 | 6.99 |
| Pre Tax Margin(%) | 5.89 | 7.6 | 7.14 | 7.74 | 4.86 | 7.02 | 6.33 | 3.9 | 4.74 | 5.64 | 5.7 |
| PAT Margin (%) | 4.29 | 5.54 | 4.82 | 5.66 | 4.19 | 5.39 | 4.9 | 3.05 | 3.6 | 4.1 | 4.14 |
| Cash Profit Margin (%) | 5.74 | 7.06 | 6.47 | 7.25 | 6.26 | 7.77 | 6.92 | 4.97 | 5.75 | 6.41 | 6.28 |
| ROA(%) | 7.59 | 8.72 | 7.45 | 9 | 6.75 | 7.35 | 8.11 | 5.37 | 6.47 | 7.22 | 7.63 |
| ROE(%) | 30.69 | 32.69 | 20.77 | 22.86 | 17.27 | 17.91 | 19.45 | 12.86 | 14.85 | 16.52 | 20.25 |
| ROCE(%) | 22.77 | 26.56 | 23.87 | 26.43 | 17.24 | 18.1 | 17.59 | 12.73 | 15.51 | 18.36 | 20.95 |
| Receivable days | 32.73 | 37.34 | 40.05 | 40.1 | 40.44 | 47.4 | 37.82 | 28.75 | 20 | 20.26 | 21.15 |
| Inventory Days | 50.43 | 54.95 | 52.62 | 49.16 | 45.46 | 52.81 | 51.36 | 52.27 | 49.91 | 49.06 | 44.46 |
| Payable days | 31.97 | 30.95 | 31.89 | 29.82 | 26.27 | 36.35 | 34.29 | 34.02 | 33.53 | 33.21 | 31.76 |
| PER(x) | 0 | 0 | 53.38 | 29.72 | 23.1 | 32.11 | 21.1 | 26.27 | 26.01 | 33.74 | 21.74 |
| Price/Book(x) | 0 | 0 | 8.68 | 5.94 | 3.86 | 4.92 | 3.75 | 3.4 | 3.73 | 6.11 | 5.08 |
| Dividend Yield(%) | 0 | 0 | 0.71 | 0.88 | 1.49 | 1.53 | 2.15 | 2.3 | 2.05 | 1.46 | 2.06 |
| EV/Net Sales(x) | 0.25 | 0.16 | 2.43 | 1.71 | 1.1 | 1.76 | 1.21 | 0.98 | 1.11 | 1.68 | 1.12 |
| EV/Core EBITDA(x) | 2.82 | 1.58 | 26.56 | 19.94 | 14.32 | 18.25 | 13.46 | 14.63 | 14.28 | 18.31 | 11.8 |
| Net Sales Growth(%) | 13.26 | 14.26 | 5.59 | 14.12 | 17.69 | -10.01 | 32.52 | 12.85 | 1.99 | -1.86 | 9.06 |
| EBIT Growth(%) | 2.45 | 46.36 | -9.51 | 22.57 | -23.66 | 28.01 | 21.03 | -21.14 | 21.75 | 18.37 | 9.19 |
| PAT Growth(%) | -12.55 | 47.78 | -8.02 | 39.15 | -13.96 | 15.63 | 20.59 | -29.53 | 21.7 | 12.22 | 10.37 |
| EPS Growth(%) | -11.48 | 31.32 | -11.19 | 43.55 | -6.95 | 2.45 | 28.29 | -25.03 | 19.1 | 19.44 | 9.99 |
| Debt/Equity(x) | 1.55 | 0.66 | 0.29 | 0.24 | 0.35 | 0.48 | 0.69 | 0.57 | 0.52 | 0.54 | 0.73 |
| Current Ratio(x) | 0.8 | 0.83 | 0.95 | 0.99 | 0.96 | 1.09 | 1.06 | 0.97 | 1.04 | 0.99 | 0.94 |
| Quick Ratio(x) | 0.42 | 0.4 | 0.49 | 0.52 | 0.56 | 0.59 | 0.52 | 0.4 | 0.41 | 0.42 | 0.48 |
| Interest Cover(x) | 5.14 | 5.34 | 9.2 | 15.08 | 9.37 | 10.75 | 9.59 | 4.81 | 5.38 | 5.15 | 5.43 |
| Total Debt/Mcap(x) | 0 | 0 | 0.03 | 0.04 | 0.09 | 0.1 | 0.18 | 0.17 | 0.14 | 0.09 | 0.14 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.05 | 74.03 | 74.03 | 67.56 | 67.56 | 67.53 | 67.53 | 67.65 | 67.74 | 67.74 |
| FII | 1.65 | 1.72 | 2.99 | 2.94 | 3.77 | 4.17 | 4.7 | 3.79 | 3.84 | 4.05 |
| DII | 12.87 | 12.11 | 10.36 | 10.4 | 9.21 | 8.08 | 7.68 | 7.89 | 8.34 | 7.71 |
| Public | 11.44 | 12.14 | 12.62 | 19.1 | 19.46 | 20.22 | 20.08 | 20.68 | 20.08 | 20.5 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 14.23 | 14.23 | 14.23 | 12.99 | 12.99 | 12.99 | 12.99 | 13.01 | 13.03 | 13.03 |
| FII | 0.32 | 0.33 | 0.57 | 0.57 | 0.73 | 0.8 | 0.9 | 0.73 | 0.74 | 0.78 |
| DII | 2.47 | 2.33 | 1.99 | 2 | 1.77 | 1.55 | 1.48 | 1.52 | 1.6 | 1.48 |
| Public | 2.2 | 2.34 | 2.43 | 3.67 | 3.74 | 3.89 | 3.86 | 3.98 | 3.86 | 3.94 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19.22 | 19.23 | 19.23 | 19.23 | 19.23 | 19.23 | 19.23 | 19.23 | 19.23 | 19.24 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +9% | +3% | +10% | +9% |
| Operating Profit CAGR | +13% | +15% | +10% | +10% |
| PAT CAGR | +10% | +15% | +5% | +9% |
| Share Price CAGR | -9% | +9% | 0% | — |
| ROE Average | +20% | +17% | +17% | +21% |
| ROCE Average | +21% | +18% | +17% | +20% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.05 | 74.03 | 74.03 | 67.56 | 67.56 | 67.53 | 67.53 | 67.65 | 67.74 | 67.74 |
| FII | 1.65 | 1.72 | 2.99 | 2.94 | 3.77 | 4.17 | 4.7 | 3.79 | 3.84 | 4.05 |
| DII | 12.87 | 12.11 | 10.36 | 10.4 | 9.21 | 8.08 | 7.68 | 7.89 | 8.34 | 7.71 |
| Public | 11.44 | 12.14 | 12.62 | 19.1 | 19.46 | 20.22 | 20.08 | 20.68 | 20.08 | 20.5 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 14.23 | 14.23 | 14.23 | 12.99 | 12.99 | 12.99 | 12.99 | 13.01 | 13.03 | 13.03 |
| FII | 0.32 | 0.33 | 0.57 | 0.57 | 0.73 | 0.8 | 0.9 | 0.73 | 0.74 | 0.78 |
| DII | 2.47 | 2.33 | 1.99 | 2 | 1.77 | 1.55 | 1.48 | 1.52 | 1.6 | 1.48 |
| Public | 2.2 | 2.34 | 2.43 | 3.67 | 3.74 | 3.89 | 3.86 | 3.98 | 3.86 | 3.94 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19.22 | 19.23 | 19.23 | 19.23 | 19.23 | 19.23 | 19.23 | 19.23 | 19.23 | 19.24 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.